VEGF inhibitors for anti-angiogenic therapy

VEGF inhibitors for anti-angiogenic therapy

Show other versions (1)
Saved in:
Bibliographic Details
Other Authors: Alitalo, Kari (Speaker)
Format: Electronic Video
Language:English
Published: London : Henry Stewart Talks, 2007.
Series:Henry Stewart talks. Biomedical & life sciences collection. Signal transduction via protein tyrosine kinase receptors : structures, function, regulation, mechanisms and role in disease.
Subjects:
Monoclonal antibodies.
Vascular endothelial growth factors > Antagonists.
Angiogenesis Inducing Agents.
Neovascularization, Physiologic.
Receptors, Vascular Endothelial Growth Factor.
Signal Transduction.
Vascular Endothelial Growth Factor Receptor-3 > antagonists & inhibitors.
Vascular Endothelial Growth Factor Receptor-3 > metabolism.
Vascular Endothelial Growth Factor Receptor-3.
Online Access:https://hstalks.com/bs/912/
Series
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Contents: Antagonist monoclonal antibodies to VEGFR-3
  • Mode of action of antagonist monoclonal antibodies
  • Functional properties of antagonist antibodies to VEGFR-3
  • In vivo effects of anti-VEGFR-3 treatment on physiological lymphangiogenesis
  • Inhibition of pathological vessel growth in the cornea
  • Anti-angiogenic effect of antibodies to VEGFR-3 in tumors
  • Inhibition of lymphatic metastasis with antagonist antibodies to VEGFR-3
  • Role of VEGFR-3 in normal and pathological immune response.

Similar Items